US 12,215,097 B2
Derivatives of substituted morpholines and uses thereof
Janak Khimchand Padia, Germantown, MD (US)
Assigned to Supernus Pharmaceuticals, Inc., Rockville, MD (US)
Filed by Supernus Pharmaceuticals, Inc., Rockville, MD (US)
Filed on Jan. 18, 2024, as Appl. No. 18/416,455.
Application 18/416,455 is a continuation of application No. 17/698,592, filed on Mar. 18, 2022, granted, now 11,919,889.
Claims priority of provisional application 63/162,671, filed on Mar. 18, 2021.
Prior Publication US 2024/0182458 A1, Jun. 6, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 413/12 (2006.01); C07D 265/30 (2006.01); C07D 413/14 (2006.01)
CPC C07D 413/12 (2013.01) [C07D 265/30 (2013.01); C07D 413/14 (2013.01)] 27 Claims
 
1. A stereoisomer of a compound of the formula:

OG Complex Work Unit Chemistry
or a salt thereof.